ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,306.04
0.02%
US Tech 100
18,387.60
0.38%
다우존스 지수
38,852.86
-0.55%
Bitcoin
68,742.58
0.66%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 독일
  5. TG
  6. Genmab AS (GE9)

  7. Genmab AS (GE9) 뉴스

GE9 Genmab AS

257.90
-4.20 (-1.60%)
29 5월(5) 2024 - 마감
실시간 데이터
기업명 주식 심볼 시장 주식 타입
Genmab AS GE9 Tradegate 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-4.20 -1.60% 257.90 06:50:06
개장가 저가 고가 종가 전일 종가
263.00 260.40 263.00 257.90 262.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/05/202423:16GLOBETransactions in Connection with Share Buy-back Program
24/05/202406:00GLOBEGenmab to Showcase Data in Various Patient Populations to be..
22/05/202400:06GLOBEGenmab Completes Acquisition of ProfoundBio
21/05/202420:19GLOBETransactions in Connection with Share Buy-back Program
14/05/202423:02GLOBEGenmab to Present New and Updated Results From Multiple..
13/05/202423:09GLOBETransactions in Connection with Share Buy-back Program
08/05/202403:27GLOBECapital Increase in Genmab as a Result of Employee Warrant..
06/05/202423:01GLOBETransactions in Connection with Share Buy-back Program
03/05/202400:01GLOBEGenmab Announces Financial Results for the First Quarter of..
30/04/202407:40GLOBETIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval..
29/04/202417:24GLOBETransactions in Connection with Share Buy-back Program..
22/04/202416:30GLOBETransactions in Connection with Share Buy-back Program..
16/04/202419:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
15/04/202417:07GLOBETransactions in Connection with Share Buy-back Program..
08/04/202418:44GLOBETransactions in Connection with Share Buy-back Program
03/04/202414:34GLOBEGenmab to Broaden and Strengthen Oncology Portfolio with..
02/04/202416:24GLOBETransactions in Connection with Share Buy-back Program
25/03/202422:30GLOBETransactions in Connection with Share Buy-back Program
18/03/202418:49GLOBECompletion of share buy-back program
15/03/202421:16GLOBEGenmab Announces Initiation of Share Buy-Back Program
14/03/202405:58GLOBETransactions with shares and linked securities in Genmab A/S..
14/03/202405:52GLOBEConstitution of the Board of Directors in Genmab A/S, Grant..
14/03/202400:13GLOBEPassing of Genmab A/S’ Annual General Meeting
11/03/202418:42GLOBETransactions in connection with share buy-back program
05/03/202403:10GLOBETransactions with shares and linked securities in Genmab A/S..
04/03/202418:29GLOBETransactions in connection with share buy-back program
02/03/202408:04GLOBETransactions with shares and linked securities in Genmab A/S..
01/03/202400:48GLOBETransactions with shares and linked securities in Genmab A/S..
28/02/202405:42GLOBETransactions with shares and linked securities in Genmab A/S..
28/02/202405:40GLOBECapital Increase in Genmab as a Result of Employee Warrant..
27/02/202409:45GLOBEU.S. FDA Accepts for Priority Review the Supplemental..
26/02/202419:21GLOBETransactions in connection with share buy-back program
24/02/202407:50GLOBETransactions with shares and linked securities in Genmab A/S..
24/02/202407:35GLOBEGrant of Restricted Stock Units to Management and Employees..
19/02/202418:40GLOBETransactions in connection with share buy-back program
15/02/202420:00GLOBENotice to Convene the Annual General Meeting of Genmab A/S
15/02/202404:09GLOBEGenmab Files Annual Report with the U.S. Securities and..
15/02/202401:41GLOBEGenmab Announces Initiation of Share Buy-Back Program
15/02/202401:02GLOBEGenmab Publishes 2023 Annual Report
02/02/202420:45GLOBETisotumab Vedotin Marketing Authorization Application..
26/01/202404:22GLOBEGrant of Restricted Stock Units and Warrants to Employees in..
23/01/202420:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
23/01/202408:40GLOBEGenmab Announces Decision in Arbitration Appeal under..
09/01/202420:45GLOBETIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
03/01/202414:55GLOBETransactions With Shares and Linked Securities in Genmab A/S..
02/01/202423:52GLOBEGenmab to Present at the 42nd Annual J.P. Morgan Healthcare..
12/12/202321:00GLOBEGenmab to Hold 2023 R&D Update and ASH Data Review Meeting
10/12/202302:00GLOBENew Pivotal Data for Bispecific Antibody Epcoritamab..
06/12/202307:26GLOBECapital Increase in Genmab as a Result of Employee Warrant..
27/11/202321:00GLOBEGenmab Announces Positive Regulatory Updates for Epcoritamab..

최근 히스토리

TG
GE9
Genmab AS
AMEX
LKI
Lazare Kaplan
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유